The Fibrolamellar Cancer Foundation establishes partnership with Dialectic Therapeutics
Effort will support a new clinical trial for fibrolamellar carcinoma, a rare cancer that primarily impacts children and young adults GREENWICH, CT, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- The Fibrolamellar Cancer Foundation (FCF) is pleased …